Monte Rosa Therapeutics Inc (GLUE)

NASDAQ · Biotechnology

14.20
+0.26 (+1.87%)
Updated Sep 1, 7:01 PM ET
AI Rating
Sell
Overall Score
40
Trend
30
Momentum
44
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 19, 2025 260 sessions Aug 31, 2026

AI Analysis

Monte Rosa Therapeutics Inc is trading at $14.20, up 1.87% on the session. The 50 day average sits at $19.51 and the 200 day at $18.52, which puts the stock in a uptrend. RSI is at 34.3, which reads as weak, and MACD is bullish crossover. Volume is average.

The nearest support is around $13.29 with resistance near $16.21, so that band frames the current range. Average daily movement is roughly $1.04, or about 7.4% of the share price, which is what any stop placement has to allow for. The overall health score of 40 out of 100 combines a trend score of 30, momentum of 44 and a risk score of 52.

Technical indicators

RSI (14)
34.3
weak
MACD
-1.536
bullish crossover
SMA 20
15.09
SMA 50
19.51
SMA 200
18.52
uptrend
ATR (14)
1.04
avg daily range
Support
13.29
Resistance
16.21
Volume vs 20d
0.93x
average
Volatility
54.4%
annualised
1 month
-15.62%
3 months
-29.13%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.